Skip to main content

Advertisement

Log in

St. John's Wort

An option for the primary care treatment of depressive patients?

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract.

This article reviews the historical background, active ingredients of St. John's Wort and the major double-blind placebo-controlled studies. Despite the two major failed clinical trials conducted in American Research Centers, most of the data reviewed support that hypericum extracts are more effective than placebo for the treatment of mild to moderate depressive illness. The authors examine the likely reasons for the failed studies and also describe drug interactions and the side effects of St. John's Wort. Those patients who are prescribed St. John's Wort should be closely monitored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-J. Möller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, R., Möller, HJ. St. John's Wort. European Archives of Psychiatry and Clinical Neurosciences 253, 140– 148 (2003). https://doi.org/10.1007/s00406-003-0417-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-003-0417-6

Key words

Navigation